| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.038 | 0.8 |